BVF INVESTMENTS LLC

CIK 1132245 · last filed 2015-11-02

BVF INVESTMENTS LLC is a corporate insider who has filed 24 SEC Form 4 insider transactions across 10 companies since 2008. The most recent filing shows the insider sold $2.1M of CCXI on Nov 2, 2015. Across all open-market trades the lifetime net is +$163.7M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.08B across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.08B

Companies

10

Total Filings

24

Lifetime Open-Market Net

$163.72M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CCXI 2,744,577 $14.52 $39.85M -$50.09M 3 2015-11-02
CBIO 16,323 $16.44 $268.4K $0 1 2015-08-21
LGND 248,144 $296.28 $73.52M $7.41M 3 2014-03-26
RIGL 112,385 $38.50 $4.33M -$7.68M 1 2013-11-20
Celera CORP (CRA) Delisted 34,656,684 $204.30M 2 2011-05-12
NBIX 10,257,894 $182.83 $1.88B -$2.39M 3 2010-04-13
FACT 7,671,129 $10.67 $81.85M $40.31M 2 2010-02-04
NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ (NTII) Delisted 4,133,897 -$25.15M 1 2009-10-23
AVIGEN INC \DE (AVGN) Delisted 15,952,630 -$3.03M 3 2009-10-23
EPIRUS Biopharmaceuticals, Inc. (CRXX) Delisted 8,404,399 $56.2K 2 2008-11-26

Recent Filings

24 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2015-11-02 CCXI Sell (S) −300,000 -$2.09M EDGAR
2015-08-21 CBIO $0 EDGAR
2015-06-11 CCXI Sell (S) −5,734,200 -$51.61M EDGAR
2014-07-10 Other (J) −2,964,552 -$13.52M
2014-03-26 LGND Sell (S) −469,356 -$32.90M EDGAR
2013-11-20 RIGL Sell (S) −2,907,732 -$7.68M EDGAR
2013-10-07 CCXI Buy (P) +656,550 $3.61M EDGAR
2011-08-10 LGND Buy (P) +3,598,200 $39.52M EDGAR
2011-05-12 Celera CORP (CRA) Delisted Buy (P) +21,537,600 $172.98M EDGAR
2011-04-11 Celera CORP (CRA) Delisted Buy (P) +3,843,750 $31.32M EDGAR
Showing 110 of 24
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.